Search for Clinical Trial Results

Status	Study
Active, not recruiting	Study Name: Cabozantinib for Plexiform Neurofibromas (PN) in Subjects With NF1 (16 Years +) Condition: NF1 Neurofibromatosis Plexiform Neur Date: 2014-03-14 Interventions: Drug: Cabozantinib Open label Phase II clinical trials. All subjects will start cabozantinib at 40 mg. S